PA
Perceptive Advisors
Micro VCActivePerceptive Advisors is a privately owned hedge fund sponsor that finances the public equity markets across the globe.
129
Investments
10
Exits
$10B
AUM
7.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Perceptive Advisors.
Investment Thesis & Strategy
Perceptive Advisors, as a hedge fund, invests in public equity markets globally, with a focus on fintech and venture capital, and may invest in companies at various stages.
Investment Activity
Deals per year over the last 6 years
1
20175
20180
20192
20203
20211
2022Portfolio Companies
Selected investments from their portfolio of 129 companies
A
Alumis
Biotech · Series B, 2022
K
Kyverna Therapeutics
Biotech · Series B, 2021
V
Ventyx Biosciences
Biotech · Series B, 2021
C
Carmot Therapeutics
Biotech · Series B, 2021
A
Acumen Pharmaceuticals
Biotech · Series A, 2020
V
Verve Therapeutics
Biotech · Series B, 2020
V
Vaxcyte
Biotech · Series B, 2018
L
Lyell Immunopharma
Biotech · Series B, 2018
G
Gossamer Bio
Biotech · Series B, 2018
C
Cerevel Therapeutics
Biotech · Series A, 2018
N
Nkarta Therapeutics
Biotech · Series B, 2018
T
Turning Point Therapeutics
Biotech · Series B, 2017
Notable Exits
CompanyTypeYearValue / Acquirer
SeagenAcquisition2023$30B
Turning Point TherapeuticsAcquisition2022$4.1B
ObsEvaIPO2017—
Myovant SciencesIPO2016—
Spark TherapeuticsIPO2015—
EpizymeIPO2013—
bluebird bioIPO2013—
Portola PharmaceuticalsIPO2013—
Intercept PharmaceuticalsIPO2012—
Acadia PharmaceuticalsIPO2004—
Frequently Asked Questions
Perceptive Advisors focuses on Seed, Series A stage investments.
Related Investors
Empire Angels
New York, United States · 28 deals
Musha Ventures
New York, United States · 5 deals
GRID Ventures
New York, United States · 2 deals
Worldwide Investor Network
New York, United States · 0 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals